| J9271 | Injection, pembrolizumab, 1 mg | 9,000 | $40 | $351K |
| J0897 | Injection, denosumab, 1 mg | 6,060 | $20 | $109.1K |
| Q5107 | Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 2,370 | $20 | $52.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 370 | $100 | $35.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 280 | $110 | $30.3K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 150 | $150 | $21.6K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 140 | $140 | $18.8K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 160 | $70 | $10.3K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 170 | $50 | $8.7K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 50 | $180 | $8.5K |